Cardiology makes up 10% of the 692 market-cleared clinical AI algorithms in the FDA’s latest update on the number of patient-facing AI now commercialized in the U.S. Experts share their thoughts on how it is being used.

AI was one of the biggest stories at the American Heart Association’s Scientific Sessions 2023 conference in Philadelphia. Researchers presented new data about heart attack care, voice recognition algorithms, digital stethoscopes and more. 

New research suggests AI could offer physicians a new, state-of-the-art approach to sudden cardiac arrest risk management.

There are now numerous AI algorithms for electrophysiology. Jagmeet Singh, MD, examined how this advanced technology is being applied.

The two new leadless pacemakers, the Micra AV2 and Micra VR2, feature much longer batteries than previous models. 

With healthcare providers under continuing pressure to provide better care at lower costs, remote cardiac monitoring devices are becoming popular and valuable patient care tools, fueling U.S. market growth expected to top more than 25 percent between 2011 and 2016.[1]  The devices enable cardiologists to monitor patients for extended periods of time outside the costly hospital environment, improving their ability to identify problems and provide early intervention that can support better outcomes and reduce the need for expensive future care.